'Hope or Hype' looks at what drives the American obsession with medical "miracles," revealing the roles of: equipment manufacturers and pharmaceutical companies; doctors and hospitals too quick to order surgery or expensive medications; the politicians; the press; and our own "technoconsumption" mindset. About the AuthorDeyo and Patrick are professors at the University of Washington. Deyo was co-recipient of the Nellie Westerman Prize for research in medical ethics. He directs a fellowship program for policy-relevant research training, as well as the university's Center for Cost and Outcomes Research. Patrick is noted for his work on the links between quality of life, cost-effectiveness, and health policy. He has worked on drug studies for a wide variety of illnesses, and is a member of the Institute of Medicine, the most prestigious organization of health experts in the U.S. Table of Contents<html> "Part I: Can There Be Too Much of a Good Thing? The Hazards of Uncritically Embracing New Medical Advances 1. Disillusioned Insiders: The Authors' Experiences 2. The Allure of the New: An American Love Affair 3. Red Herrings, Side Effects, and Superbugs: Why More Isn't Always Better 4. Social Hazards: Why Things Don't Always Work as Planned Part II: How Things Work: Opinion Makers and Regulators 5. What Will You Swallow? How Drug Companies Get You to Buy Expensive Drugs ofDubious Value 6. Making Friends, Playing Monopoly, and Dirty Tricks: Other Drug Company Strategies 7. Stacking the Deck: How Industry Gets the "Right" Answer in Clinical Research 8. Hype and Horror: The Media's Role in Disseminating New Treatments 9. Doctors and the Health Care Industry: "More Is Always Better" 10. Politicians and Judges: Practicing Medicine Without a License? 11. Advocacy Groups: Mother Theresa's Waiting Room 12. Holes in the Safety Net: the FDA and the FTC Part III: Useless, Harmful, or Marginal: Popular Treatments That Caused Unnecessary Disability, Dollars, or Death 13. Ineffective or Inferior New Drugs 14. Medical Devices of Uncertain Value 15. Unnecessary or Excessive Surgery 16. Diet and Weight Loss Aids/ "Lifestyle" Treatments Part IV: Crossing the Threshold: Improving the Transition from "Experimental" to "Standard Care" 17. Evidence-based Medicine: A Surprisingly New Idea 18. Pay Now or Pay Later: Closer Collaboration Between Researchers and Payers 19. Getting Value for Money: An Issue We Can't Ignore 20. Reducing Snake Oil Sales: National Centers to Assess Efficacy, Safety, and CostEffectivess of New Treatments 21. Shared Decision Making: Empowering Patients and the Public" Reviews Foreword: "This cautionary book warns consumers, doctors, pharmaceutical executives, politicians, and the media all to step back and prevent this medical carousel from going any faster." |
Help
My Cart
